Status:
UNKNOWN
Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer
Lead Sponsor:
Peking University Cancer Hospital & Institute
Collaborating Sponsors:
Geneplus-Beijing Co. Ltd.
Conditions:
NSCLC
Eligibility:
All Genders
18-80 years
Brief Summary
Stratification of postoperative ctDNA status can effectively assess the risk of recurrence in patients. In addition, the multi-node dynamic monitoring of ctDNA is more effective in predicting the recu...
Detailed Description
In this prospective study, 65 patients with potentially operable non-small cell lung cancer without driving gene EGFR/ALK mutation in stage III were enrolled in this prospective study. peripheral bloo...
Eligibility Criteria
Inclusion
- Capable of giving signed informed consent, age ≥ 18 and ≤ 80.
- patients with stage Ⅲ non-small cell lung cancer confirmed by histology or cytology have potential surgical opportunities.
- No driving gene EGFR/ALK mutation.
- PS = 0-1.
- the treatment process cooperated with the provision of clinicopathological and imaging data needed in the research process, followed up and collected the blood of the clinical efficacy evaluation nodes, and agreed to use the test data for follow-up research and product development.
Exclusion
- patients suffering from other malignant tumors.
- patients change the treatment regimen before receiving the specified treatment or before the disease progresses.
- Patients could not cooperate with the study for follow-up according to the defined clinical follow-up period;
- Patients were unable to accept or provide imaging and other designated therapeutic evaluation means.
Key Trial Info
Start Date :
November 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06081777
Start Date
November 25 2022
End Date
June 1 2025
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yuyan Wang
Beijing, China, 100142